Recent Finacing
Recent Raise
Trace Neuroscience, based in South San Francisco, develops antisense oligonucleotides targeting UNC13A mRNA to correct splicing in ALS and TDP‑43–related neurodegenerative diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Trace Neuroscience.
